Welcome to Crene Biotechnology!


CPhI China will open its gates again on 20 - 22 June 2018"CPhI China is a great way to tap into the market and connect with the potential suppliers from all over the world. Aside from networking with existing suppliers, it provides an opportunity to learn..
Taizhou Crene Biotechnology Co., Ltd. ATTEND THE CPHI INDIA 28-30 Nov 2017.Crene mainly produces pharmaceutical intermediates, such asIdelalisib intermediates 870281-86-0, Tedizolid intermediates 856866-72-3, Afatinib intermediates 314771-76-1, Ninteda..
Manufactory for Rucaparib - Idelalisib-Palbociclib -Macitentan-Lenvatinib(E7080)-Olaparib-AZD9291-Afatinib intermediates, warmly welcome CPHI Korea 22 - 24 JAugust 2017, COEX, Seoul, Korea.Visit us at : F32
Taizhou Crene Biotechnology Co., Ltd.is specialized in the manufacture of APIs, pharmaceutical intermediates. Our company is located in the largest API base in China--Taizhou and Cooperated to established GMP standard production base and laboratory in surround..
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Friendly link:

Copyright Copyright (C) 2018-2021 Taizhou Crene Biotechnology Co.,Ltd.  

Address:Economic Developed Zone of Taizhou Zhejiang China